← United States · Coverage record
US · SEC FORM 4
MapLight Therapeutics, Inc.
MPLT · Nasdaq · CIK 0001770069 · Healthcare · Biotechnology
INSIDER SIGNAL
5 qualifying P purchase groups
in the current 180-day scoring window
133 Form 4 transaction lines observed in the same window
114 sales · 13 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: Director, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-08-14 · Catalyst4, Inc..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 3,148,094
- Previous report
- 3,297,011
- Avg daily volume
- 542,975
- Days to cover
- 5.8
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 4,400,000 | USD 11.38 | USD 50,072,000 | SEC filing ↗ |
| 2026-07-30 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 1,000,000 | USD 13.00 | USD 13,000,000 | SEC filing ↗ |
| 2026-07-29 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 3,000 | USD 12.63 | USD 37,890 | SEC filing ↗ |
| 2026-07-28 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 206,225 | USD 11.04 | USD 2,276,737 | SEC filing ↗ |
| 2026-07-28 | Cox Troy | Purchase (P) | Voting Common Stock | 15,620 | USD 9.52 | USD 148,702 | SEC filing ↗ |
| 2026-02-20 | Pavlov George | Purchase (P) | Voting Common Stock | 9,920 | USD 17.86 | USD 177,171 | SEC filing ↗ |
| 2026-02-19 | Pavlov George | Purchase (P) | Voting Common Stock | 4,422 | USD 17.57 | USD 77,695 | SEC filing ↗ |
| 2026-02-18 | Pavlov George | Purchase (P) | Voting Common Stock | 10,658 | USD 17.48 | USD 186,302 | SEC filing ↗ |
| 2026-02-10 | Garnett Timothy John | Purchase (P) | Voting Common Stock | 14,124 | USD 17.89 | USD 252,678 | SEC filing ↗ |
| 2025-10-28 | Novo Holdings A/S | Purchase (P) | Voting Common Stock | 952,941 | USD 17.00 | USD 16,199,997 | SEC filing ↗ |
| 2025-10-28 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 5,441,176 | USD 17.00 | USD 92,499,992 | SEC filing ↗ |
Form 4 evidence
198 transaction lines in the latest 365-day window; 198 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Lillie James Woodruff | Sale (S) | Voting Common Stock | 11,513 | USD 8.08 | USD 93,025 | SEC filing ↗ |
| 2026-10-15 | Kroeger Christopher A. | Sale (S) | Voting Common Stock | 73,691 | USD 8.08 | USD 595,423 | SEC filing ↗ |
| 2026-10-15 | Kreitzer Anatol | Sale (S) | Voting Common Stock | 12,248 | USD 7.84 | USD 96,024 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Lillie James Woodruff | Sale (S) | Voting Common Stock | 11,513 | USD 8.08 | USD 93,025 | SEC filing ↗ |
| 2026-10-15 | Kroeger Christopher A. | Sale (S) | Voting Common Stock | 73,691 | USD 8.08 | USD 595,423 | SEC filing ↗ |
| 2026-10-15 | Kreitzer Anatol | Sale (S) | Voting Common Stock | 12,248 | USD 7.84 | USD 96,024 | SEC filing ↗ |
| 2026-10-15 | Hanson Kristopher | Sale (S) | Voting Common Stock | 9,020 | USD 8.08 | USD 72,882 | SEC filing ↗ |
| 2026-10-15 | GILLIS JONATHAN | Sale (S) | Voting Common Stock | 10,167 | USD 8.08 | USD 82,149 | SEC filing ↗ |
| 2026-10-15 | Foff Erin Pennock | Sale (S) | Voting Common Stock | 15,355 | USD 8.08 | USD 124,068 | SEC filing ↗ |
| 2026-09-16 | Hanson Kristopher | Sale (S) | Voting Common Stock | 16,509 | USD 11.67 | USD 192,660 | SEC filing ↗ |
| 2026-08-17 | Lillie James Woodruff | Award / grant (A) | Voting Common Stock | 7,730 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-17 | Kroeger Christopher A. | Award / grant (A) | Voting Common Stock | 23,145 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-17 | Kreitzer Anatol | Award / grant (A) | Voting Common Stock | 6,020 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-17 | Hanson Kristopher | Award / grant (A) | Voting Common Stock | 7,730 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-17 | GILLIS JONATHAN | Award / grant (A) | Voting Common Stock | 8,242 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-17 | Foff Erin Pennock | Award / grant (A) | Voting Common Stock | 13,360 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-14 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 4,400,000 | USD 11.38 | USD 50,072,000 | SEC filing ↗ |
| 2026-08-03 | Lillie James Woodruff | Sale (S) | Voting Common Stock | 22,082 | USD 12.54 | USD 276,908 | SEC filing ↗ |
| 2026-07-30 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 1,000,000 | USD 13.00 | USD 13,000,000 | SEC filing ↗ |
| 2026-07-29 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 3,000 | USD 12.63 | USD 37,890 | SEC filing ↗ |
| 2026-07-28 | Catalyst4, Inc. | Purchase (P) | Voting Common Stock | 206,225 | USD 11.04 | USD 2,276,737 | SEC filing ↗ |
| 2026-07-28 | Cox Troy | Purchase (P) | Voting Common Stock | 15,620 | USD 9.52 | USD 148,702 | SEC filing ↗ |
| 2026-07-17 | Kreitzer Anatol | Sale (S) | Voting Common Stock | 17,173 | USD 37.60 | USD 645,719 | SEC filing ↗ |
| 2026-07-17 | GILLIS JONATHAN | Sale (S) | Voting Common Stock | 18,469 | USD 37.60 | USD 694,463 | SEC filing ↗ |
| 2026-07-17 | Lillie James Woodruff | Sale (S) | Voting Common Stock | 2,077 | USD 37.90 | USD 78,718 | SEC filing ↗ |
| 2026-07-17 | Kroeger Christopher A. | Sale (S) | Voting Common Stock | 16,779 | USD 37.90 | USD 635,924 | SEC filing ↗ |
| 2026-07-17 | Hanson Kristopher | Sale (S) | Voting Common Stock | 1,130 | USD 37.90 | USD 42,827 | SEC filing ↗ |
| 2026-07-17 | Foff Erin Pennock | Sale (S) | Voting Common Stock | 3,656 | USD 37.90 | USD 138,562 | SEC filing ↗ |
| 2026-07-16 | Kreitzer Anatol | Sale (S) | Voting Common Stock | 9,056 | USD 36.80 | USD 333,235 | SEC filing ↗ |
| 2026-07-16 | GILLIS JONATHAN | Sale (S) | Voting Common Stock | 8,455 | USD 36.80 | USD 311,112 | SEC filing ↗ |
| 2026-07-16 | Lillie James Woodruff | Sale (S) | Voting Common Stock | 8,547 | USD 36.79 | USD 314,412 | SEC filing ↗ |
| 2026-07-16 | Kroeger Christopher A. | Sale (S) | Voting Common Stock | 69,082 | USD 36.79 | USD 2,541,341 | SEC filing ↗ |
| 2026-07-16 | Hanson Kristopher | Sale (S) | Voting Common Stock | 8,118 | USD 36.78 | USD 298,616 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | MPLT |
| CIK | 0001770069 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 198 transaction lines from 2025-10-27 to 2026-10-15 12 P purchase lines · 145 S sale lines · 41 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.